A Study to Assess DV-601 in Subjects With Chronic Hepatitis B
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if DV-601, an investigational, therapeutic vaccine
will be well-tolerated and induce hepatitis B virus (HBV)-specific virological and
immunological responses in chronic hepatitis B (CHB) patients.